Litcius/Paper detail

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Liwen Hua, Qiuyue Zhang, Xinyue Zhu, Ruoning Wang, Qidong You, Lei Wang

2022Journal of Medicinal Chemistry65 citationsDOI

Abstract

In recent years, with the successful development of proteolysis-targeting chimeric molecules (PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug design, especially small-molecule drugs, has been increasingly recognized. Inspired by PROTACs, diverse heterobifunctional molecules have been reported to simultaneously bind two or more molecules and bring them into proximity to interaction, such as ribonuclease-recruiting, autophagy-recruiting, lysosome-recruiting, kinase-recruiting, phosphatase-recruiting, glycosyltransferase-recruiting, and acetyltransferase-recruiting chimeras. On the basis of the heterobifunctional principle, more opportunities for advancing drug design by linking potential effectors to a protein of interest (POI) have emerged. Herein, we introduce heterobifunctional molecules other than PROTACs, summarize the limitations of existing molecules, list the main challenges, and propose perspectives for future research directions, providing insight into alternative design strategies based on substrate-proximity-based targeting.

Topics & Concepts

EffectorChemistrySmall moleculeComputational biologyDrug discoveryProteolysisBiochemistryCell biologyNanotechnologyEnzymeBiologyMaterials scienceProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisUbiquitin and proteasome pathways